Roche
Roche’s Newly Approved Companion Diagnostic May Open Treatment Options for HER2-low Patients
2022-10-06
Roche Buys Good Therapeutics For $250 Million Upfront, Obtains Immune Stimulating Antibody Conjugate Program
2022-09-08